Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

TNF-alpha inhibitors can cause various immune-related skin issues.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Monitoring for adverse effects in clinical treatments is crucial.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Epigenetic factors play a crucial role in skin health and disease.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

New mouse models of Pemphigus show severe symptoms and need better treatments.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Exosomes from platelet-rich plasma may help heal wounds but need more research for hair growth and skin use.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

SKPs are similar to adult skin stem cells and could help in skin repair and hair growth.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.